Gene polymorphisms and gene scores linked to low serum carotenoid status and their associations with metabolic disturbance and depressive symptoms in African-American adults

British Journal of Nutrition

Volumn 112, Issue 6, 2014, Pages 992-1003

  Beydoun, May A ^a   Nalls, Michael A ^a   Canas, J Atilio ^b   Evans, Michele K ^a   Zonderman, Alan B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NEMOURS CHILDREN S CLINIC   (United States)

Author keywords

Carotenoids; Depressive symptoms; Gene polymorphisms; Gene risk scores; Metabolic disturbance

Indexed keywords

ALPHA CAROTENE; BETA CAROTENE; BETA CRYPTOXANTHIN; C REACTIVE PROTEIN; CAROTENOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; XANTHOPHYLL; ZEAXANTHIN; ALPHA-CAROTENE; CRYPTOXANTHIN;

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DYSLIPIDEMIA; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HYPERURICEMIA; LOW SPECIFIC CAROTENOID RISK SCORE; LOW TOTAL CAROTENOID RISK SCORE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; PREDICTION; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; VITAMIN BLOOD LEVEL; BLOOD; COHORT ANALYSIS; DYSLIPIDEMIAS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEALTH SURVEY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; VITAMIN D DEFICIENCY;

ADULT; AFRICAN AMERICANS; BALTIMORE; CAROTENOIDS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CRYPTOXANTHINS; DEPRESSION; DYSLIPIDEMIAS; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; VITAMIN D DEFICIENCY;

EID: 84911861467     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514001706     Document Type: Article

References (70)

1. Soory M (2009) Relevance of nutritional antioxidants in metabolic syndrome, ageing and cancer: potential for therapeutic targeting. Infect Disord Drug Targets 9, 400-414.
2. Rao AV & Rao LG (2007) Carotenoids and human health. Pharmacol Res 55, 207-216.
3. Voutilainen S, Nurmi T, Mursu J, et al. (2006) Carotenoids and cardiovascular health. Am J Clin Nutr 83, 1265-1271.
4. Montonen J, Knekt P, Jarvinen R, et al. (2004) Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27, 362-366.
5. Coyne T, Ibiebele TI, Baade PD, et al. (2005) Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr 82, 685-693.
6. Ford ES, Will JC, Bowman BA, et al. (1999) Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 149, 168-176.
7. Hozawa A, Jacobs DR Jr, Steffes MW, et al. (2006) Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 163, 929-937.
8. Reunanen A, Knekt P, Aaran RK, et al. (1998) Serum antioxidants and risk of non-insulin dependent diabetes mellitus. Eur J Clin Nutr 52, 89-93.
9. Ford ES, Mokdad AH, Giles WH, et al. (2003) The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52, 2346-2352.
10. Beydoun MA, Shroff MR, Chen X, et al. (2011) Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys. J Nutr 141, 903-913.
11. Beydoun MA, Canas JA, Beydoun HA, et al. (2012) Serum antioxidant concentrations and metabolic syndrome are associated among U.S. adolescents in recent national surveys. J Nutr 142, 1693-1704.
12. Beydoun MA, Beydoun HA, Boueiz A, et al. (2013) Antioxidant status and its association with elevated depressive symptoms among US adults: National Health and Nutrition Examination Surveys 2005-6. Br J Nutr 109, 1714-1729.
13. Milaneschi Y, Bandinelli S, Penninx BW, et al. (2012) The relationship between plasma carotenoids and depressive symptoms in older persons. World J Biol Psychiatry 13, 588-598.
14. Kataja-Tuomola M, Sundell JR, Mannisto S, et al. (2008) Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes. Diabetologia 51, 47-53.
15. Liu S, Ajani U, Chae C, et al. (1999) Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial. JAMA 282, 1073-1075.
16. Wang L, Liu S, Pradhan AD, et al. (2006) Plasma lycopene, other carotenoids, and the risk of type 2 diabetes in women. Am J Epidemiol 164, 576-585.
17. Wang L, Liu S, Manson JE, et al. (2006) The consumption of lycopene and tomato-based food products is not associated with the risk of type 2 diabetes in women. J Nutr 136, 620-625.
18. Beydoun MA, Kuczmarski MT, Mason MA, et al. (2009) Role of depressive symptoms in explaining socioeconomic status disparities in dietary quality and central adiposity among US adults: a structural equation modeling approach. Am J Clin Nutr 90, 1084-1095.
19. Kimura Y, Matsushita Y, Nanri A, et al. (2011) Metabolic syndrome and depressive symptoms among Japanese men and women. Environ Health Prev Med 16, 363-368.
20. Akbaraly TN, Ancelin ML, Jaussent I, et al. (2011) Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. Diabetes Care 34, 904-909.
21. Herron KL, McGrane MM, Waters D, et al. (2006) The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggs. J Nutr 136, 1161-1165.
22. Borel P (2012) Genetic variations involved in interindividual variability in carotenoid status. Mol Nutr Food Res 56, 228-240.
23. Borel P, Moussa M, Reboul E, et al. (2007) Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J Nutr 137, 2653-2659.
24. Ortega H, Castilla P, Gomez-Coronado D, et al. (2005) Influence of apolipoprotein E genotype on fat-soluble plasma antioxidants in Spanish children. Am J Clin Nutr 81, 624-632.
25. Purcell S, Neale B, Todd-Brown K, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575.
26. Epstein MP, Duren WL & Boehnke M (2000) Improved inference of relationship for pairs of individuals. Am J Hum Genet 67, 1219-1231.
27. Pritchard JK, Stephens M & Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155, 945-959.
28. Hendrickson SJ, Hazra A, Chen C, et al. (2012) β-Carotene 15, 150-monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent. Am J Clin Nutr 96, 1379-1389.
29. Falush D, Stephens M & Pritchard JK (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164, 1567-1587.
30. Herbeth B, Gueguen S, Leroy P, et al. (2007) The lipoprotein lipase serine 447 stop polymorphism is associated with altered serum carotenoid concentrations in the Stanislas Family Study. J Am Coll Nutr 26, 655-662.
31. Evans MK, Lepkowski JM, Powe NR, et al. (2010) Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS): overcoming barriers to implementing a longitudinal, epidemiologic, urban study of health, race, and socioeconomic status. Ethn Dis 20, 267-275.
32. Lietz G, Oxley A, Leung W, et al. (2012) Single nucleotide polymorphisms upstream from the b-carotene 15, 150-monoxygenase gene influence provitamin A conversion efficiency in female volunteers. J Nutr 142, 161S-165S.
33. Reich DE, Cargill M, Bolk S, et al. (2001) Linkage disequilibrium in the human genome. Nature 411, 199-204.
34. Grimsby JL, Porneala BC, Vassy JL, et al. (2012) Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the Third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet 13, 30.
35. Wallace TM, Levy JC & Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27, 1487-1495.
36. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
37. Anonymous (2003) Handbook of Diagnostic Tests, 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins.
38. Ridker PM, Cushman M, Stampfer MJ, et al. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336, 973-979.
39. National Institute of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), North American Association for the Study of Obesity (NAASO) (2000) The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults, No. 00-4084. Bethesda, MD: NIH.
40. National Institute of Health (NIH) (2001) Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. NIH Publication No. 01-3670. Bethesda, MD: National Institute of Health.
41. Lezak MD, Howeison DB & Loring DW (2004) Neuropsychological Assessment, 4th ed. New York, NY: Oxford University Press.
42. Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1, 385-401.
43. Nguyen HT, Kitner-Triolo M, Evans MK, et al. (2004) Factorial invariance of the CES-D in low socioeconomic status African Americans compared with a nationally representative sample. Psychiatry Res 126, 177-187.
44. STATA (2013) Statistics/Data Analysis: Release 13.0. College Station, TX: Stata Corporation.
45. Junyent M, Tucker KL, Smith CE, et al. (2009) The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study. J Lipid Res 50, 565-573.
46. Wojczynski MK, Gao G, Borecki I, et al. (2010) Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study. J Lipid Res 51, 3316-3323.
47. Perez-Martinez P, Perez-Jimenez F, Ordovas JM, et al. (2007) The APOB-516C/T polymorphism has no effect on lipid and apolipoprotein response following changes in dietary fat intake in a healthy population. Nutr Metab Cardiovasc Dis 17, 224-229.
48. Perez-Martinez P, Perez-Jimenez F, Ordovas JM, et al. (2007) Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population. Lipids 42, 143-150.
49. Perez-Martinez P, Perez-Jimenez F, Ordovas JM, et al. (2007) The APOB-516C/T polymorphism is associated with differences in insulin sensitivity in healthy males during the consumption of diets with different fat content. Br J Nutr 97, 622-627.
50. Hammoud A, Gastaldi M, Maillot M, et al. (2010) APOB-516 T allele homozygous subjects are unresponsive to dietary changes in a three-month primary intervention study targeted to reduce fat intake. Genes Nutr 5, 29-37.
51. Weinberg RB, Gallagher JW, Fabritius MA, et al. (2012) ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins. J Lipid Res 53, 736-743.
52. Feitosa MF, An P, Ordovas JM, et al. (2011) Association of gene variants with lipid levels in response to fenofibrate is influenced by metabolic syndrome status. Atherosclerosis 215, 435-439.
53. Morabia A, Cayanis E, Costanza MC, et al. (2003) Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors. Hum Mol Genet 12, 2733-2743.
54. Ziouzenkova O, Orasanu G, Sukhova G, et al. (2007) Asymmetric cleavage of beta-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferatoractivated receptor responses. Mol Endocrinol 21, 77-88.
55. Perry JR, Ferrucci L, Bandinelli S, et al. (2009) Circulating beta-carotene levels and type 2 diabetes-cause or effect? Diabetologia 52, 2117-2121.
56. Dastani Z, Pajukanta P, Marcil M, et al. (2010) Fine mapping and association studies of a high-density lipoprotein cholesterol linkage region on chromosome 16 in French-Canadian subjects. Eur J Hum Genet 18, 342-347.
57. Love-Gregory L, Sherva R, Sun L, et al. (2008) Variants in the CD36 gene associate with the metabolic syndrome and high - density lipoprotein cholesterol.HumMol Genet 17, 1695-1704.
58. Borel P, de Edelenyi FS, Vincent-Baudry S, et al. (2011) Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans. Ann Med 43, 47-59.
59. Bayoumy NM, El-Shabrawi MM & Hassan HH (2012) Association of cluster of differentiation 36 gene variant rs1761667 (G > A) with metabolic syndrome in Egyptian adults. Saudi Med J 33, 489-494.
60. Keller KL, Liang LC, Sakimura J, et al. (2012) Common variants in the CD36 gene are associated with oral fat perception, fat preferences, and obesity in African Americans. Obesity (Silver Spring) 20, 1066-1073.
61. Borel P, Moussa M, Reboul E, et al. (2009) Human fasting plasma concentrations of vitamin E and carotenoids, and their association with genetic variants in apo C-III, cholesteryl ester transfer protein, hepatic lipase, intestinal fatty acid binding protein and microsomal triacylglycerol transfer protein. Br J Nutr 101, 680-687.
62. Liu Y, Zhou D, Zhang Z, et al. (2011) Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population. J Lipid Res 52, 354-360.
63. Lu Y, Dolle ME, Imholz S, et al. (2008) Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations. J Lipid Res 49, 2582-2589.
64. Turkovic LF, Pizent A, Dodig S, et al. (2012) FABP2 gene polymorphism and metabolic syndrome in elderly people of Croatian descent. Biochem Med (Zagreb) 22, 217-224.
65. Webster RJ, Warrington NM, Weedon MN, et al. (2009) The association of common genetic variants in the APOA5, LPL and GCK genes with longitudinal changes in metabolic and cardiovascular traits. Diabetologia 52, 106-114.
66. Sagoo GS, Tatt I, Salanti G, et al. (2008) Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol 168, 1233-1246.
67. Tai ES, Adiconis X, Ordovas JM, et al. (2003) Polymorphisms at the SRBI locus are associated with lipoprotein levels in subjects with heterozygous familial hypercholesterolemia. Clin Genet 63, 53-58.
68. Acton S, Osgood D, Donoghue M, et al. (1999) Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 19, 1734-1743.
69. Osgood D, Corella D, Demissie S, et al. (2003) Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: The Framingham Study. J Clin Endocrinol Metab 88, 2869-2879.
70. McCarthy JJ, Lehner T, Reeves C, et al. (2003) Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease. J Med Genet 40, 453-458.